申请人:STORM THERAPEUTICS LTD
公开号:WO2020201773A1
公开(公告)日:2020-10-08
The present invention relates to compounds of formula (I) that function as inhibitors of METTL3 (N6-adenosine-methyltransferase 70 kDa subunit) enzyme activity: X-Y-Z5 (I) wherein X, Y and Z are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, and autoimmune diseases, as well as other diseases or conditions in which METTL3 activity 10 is implicated.
本发明涉及作为METTL3(N6-腺苷甲基转移酶70kDa亚基)酶活性抑制剂的化合物(I)的公式,其中X、Y和Z分别如本文所定义。本发明还涉及制备这些化合物的方法,包括含有它们的药物组合物,以及它们在治疗增殖性疾病(如癌症)和自身免疫疾病以及METTL3活性有关的其他疾病或病况中的用途。